Complement C5 mAb in the Treatment of Anti-GBM Disease

Clinical trial NCT06513338 · COMPLETED

Trial details

NCT number: NCT06513338
Sponsor: Peking University First Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2024-03-01
Primary completion: 2025-11-03
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.